Ecovyst Inc. · NYSE:ECVT
Ecovyst — Deutsche Bank 15th Annual Global Industrials, Materials & Building Products Conference 202 (June 2025)
24 slides from Ecovyst's conference presentation, Jun 5, 2025
Slide 1: Deutsche Bank 15th Annual Global Industrials, Materials & Building Products Conference
Deutsche Bank 15th Annual Global Industrials, Materials & Building Products Conference June 5, 2025 Your Catalyst for Positive Change
Slide 2: Legal Discussion: Forward-Looking Statements
Legal Discussion Forward-Looking Statements Some of the information contained in this presentation, the conference call during which this presentation is reviewed and any discussions that follow constitutes “forward-looking statements.” Forward-looking statements can be identified by words such as “
Slide 3: Legal Discussion: Supply Share and Industry Information
Legal Discussion Supply Share and Industry Information Certain statistical information used in this presentation is based on independent industry publications, reports by research firms or other published independent sources. Some statistical information is also based on our good faith estimates whi
Slide 4: Ecovyst Business Profile & Value Proposition
Ecovyst Business Profile & Value Proposition An Industry-leading Provider of Specialty Catalysts and Services into Key End Uses • Favorable long-term organic growth trends driven by end use demand and growing need for sustainable products and services • Revenue visibility arising from customer colla
Slide 5: Ecovyst Reporting Segments
Ecovyst Reporting Segments Advanced Materials & Catalysts $106 Million 2024 Advanced Silicas Sales $598 Million 2024 Sales $117 Million 2024 Zeolyst Joint Venture Sales2 $200 Million 2024 Adjusted EBITDA1 $65 Million 2024 Adjusted EBITDA1 Regeneration Virgin Sulfuric Treatment Advanced Services Acid
Slide 6: Ecoservices Financial Highlights
Ecoservices Financial Highlights 2024 Sales - $598 Million 2024 Adjusted EBITDA1 - $200 Million Business Overview Demand Drivers Leading North American provider of sulfuric acid regeneration services • Customer ~10% reduction Achieveexpansion of alkylation units Regeneration in natural gas usage • G
Slide 7: Advanced Materials & Catalysts Financial Highlights
Advanced Materials & Catalysts Financial Highlights 2024 Advanced Silicas Sales - $106 Million 2024 Zeolyst Joint Venture Sales1 - $117 Million 2024 Adjusted EBITDA2,3 - $65 Million Business Overview Demand Drivers From concept to pilot to production 2X market growth from Industrial markets: Achieve
Slide 8: Strategy for Creating Shareholder Value
Strategy for Creating Shareholder Value Strengthen Leading Positions in Core Segments Regeneration • Maximize production capabilities and reliability via digitization, Hydrocracking AI, and efficiency gains Treatment Services Emissions Controls • Deliver strong margins and cash generation through co
Slide 9: First Quarter 2025 Financial Performance
First Quarter 2025 Financial Performance
Slide 10: Q1 2025 Key Highlights
Key Highlights Q1 2025 Key Highlights $162 Mln $39 Mln 20% GAAP Sales Adj. EBITDA Adj. EBITDA Margin Q1 2025 Q1 20251 Q1 20251,2 3.2x $(13) Mln $201 Mln Net Debt Leverage Adjusted Liquidity5 Ratio1,4 Free Cash Flow 1,3 1. See Appendix for reconciliations of Non-GAAP financial measures 2. Adjusted EB
Slide 11: Financial Performance - Q1 2025
Financial Performance - Q1 2025 First Quarter Financial Results First First Quarter Quarter $ % ($ in millions) 2025 2024 Change Change Ecovyst Sales 162.2 160.5 1.7 1.1 Zeolyst Joint Venture Sales 37.7 23.5 14.2 60.4 Net (Loss) Income (3.6) 1.2 (4.8) NM Net (Loss) Income Margin (%) (2.2) 0.7 NM Adj
Slide 12: Ecoservices - Q1 2025 Financial Performance
Ecoservices - Q1 2025 Financial Performance First First Quarter Quarter $ % ($ in millions) 2025 2024 Change Change Sales 143.1 141.6 1.5 1.1 Adjusted EBITDA1 28.5 41.5 (13.0) (31.3) Adjusted EBITDA Margin1 (%) 19.9 29.3 (940 bps) Capital Expenditures2 16.4 13.0 Highlights • Change in sales reflects
Slide 13: Advanced Materials & Catalysts - Q1 2025 Financial Performance
Advanced Materials & Catalysts - Q1 2025 Financial Performance First First Quarter Quarter $ % ($ in millions) 2025 2024 Change Change Advanced Silicas Sales 19.1 18.9 0.2 1.1 Zeolyst Joint Venture Sales 37.7 23.5 14.2 60.4 Adjusted EBITDA1 17.5 11.1 6.4 57.7 Adjusted EBITDA Margin1,2 (%) 30.8 26.2
Slide 14: Cash & Leverage
Cash & Leverage 1 2 4 $60.0 Cash Generation Leverage Ratio and Debt Profile • Continued favorable cash flow from operations • No significant debt maturities until 2031 • Q1 2025 decrease vs. Q1 2024 primarily driven by • No maintenance covenants on leverage timing of dividends from the Zeolyst Joint
Slide 15: Appendix
APPENDIX
Slide 16: Annual Segment Sales, Adjusted EBITDA and Margins
Annual Segment Sales, Adjusted EBITDA and Margins Trailing Twelve Months Ended (TTM) Year Ended December 31, ($ in millions, except %) March 31, 2025 2024 2023 2022 2021 Sales: Ecoservices 599.8 598.3 584.8 702.5 500.5 Advanced Materials & Catalysts1 106.4 106.2 106.3 117.7 110.7 Total sales 706.2 7
Slide 17: Quarterly Segment Sales, Adjusted EBITDA and Margins
Quarterly Segment Sales, Adjusted EBITDA and Margins Three Months Ended ($ in millions, except %) March 31, 2025 March 31, 2024 Sales: Ecoservices 143.1 141.6 Advanced Materials & Catalysts1 19.1 18.9 Total sales 162.2 160.5 Zeolyst Joint Venture sales 37.7 23.5 Adjusted EBITDA2: Ecoservices 28.5 41
Slide 18: Sales and Adjusted EBITDA Major Change Factors
Sales and Adjusted EBITDA Major Change Factors Sales Three Months Ended March 31, 2025 Advanced Sales Materials & (in $ millions and %) Ecovyst Ecoservices Catalysts Sales: $ % $ % $ % Volume (4.3) (2.6) (4.5) (3.1) 0.2 1.1 Price/Mix 6.0 3.7 6.0 4.2 — — Sales Change 1.7 1.1 1.5 1.1 0.2 1.1 Adjusted
Slide 19: Reconciliation of Net (Loss) Income to Adjusted EBITDA
Reconciliation of Net (Loss) Income to Adjusted EBITDA Three Months Ended TTM Year Ended December 31, December 31, December 31, December 31, ($ in millions, except %) March 31, 2025 March 31, 2025 2024 2023 2022 2021 Reconciliation of net (loss) income to Adjusted EBITDA Net (loss) income (3.6) (11.
Slide 20: Reconciliation of Net (Loss) Income to Adjusted EBITDA
Reconciliation of Net (Loss) Income to Adjusted EBITDA Three Months Twelve Months Ended TTM Three Months Ended Ended March 31, March 31, June 30, September 30, December 31, December 31, ($ in millions, except %) March 31, 2025 2025 2024 2024 2024 2024 2024 Reconciliation of net (loss) income to Adju
Slide 21: Descriptions for reconciliation of Non-GAAP financial measures
Descriptions for reconciliation of Non-GAAP financial measures a. We use Adjusted EBITDA as a performance measure to evaluate our financial results. Because our Advanced Materials & Catalysts segment reflects our 50% portion of the earnings from the Zeolyst Joint Venture, we include an adjustment fo
Slide 22: Adjusted Free Cash Flow
Adjusted Free Cash Flow Three months ended Full Year Three months ended ($ in millions) March 31, 2024 2024 March 31, 2025 Net cash provided by operating activities 36.5 149.9 10.3 Less: Purchases of property, plant and equipment1 17.4 69.0 24.3 Free Cash Flow 19.1 80.9 (14.0) Cash paid for debt fin
Slide 23: Net Debt Leverage Ratio
Net Debt Leverage Ratio ($ in millions, except %) March 31, 2024 June 30, 2024 September 30, 2024 December 31, 2024 March 31, 2025 Total debt 875.3 873.0 873.0 870.8 868.6 Less: Cash and cash equivalents 103.1 83.3 123.5 146.0 127.5 Net debt 772.2 789.7 749.5 724.8 741.1 Net income (loss) 73.9 56.1
Slide 24: Your Catalyst for Positive Change
Your Catalyst for Positive Change